Partnering with Oncobiologics
Partnerships are a critical part of the Oncobiologics growth strategy. To date, the company has engaged with leading pharmaceutical and biotechnology companies to explore the joint advancement of our our proprietary programs, while retaining significant value in the downstream potential of our partnered programs.
The company is actively exploring alliances that complement our expertise in biologics product development with important scientific, clinical and business capabilities. These alliances may incorporate our technology platforms, product candidates and biologic product development capabilities.
To inquire regarding partnership opportunities with Oncobiologics, please contact:
Stephen McAndrew, Ph.D.
Vice President, Business Development
609-619-3990 ext. 216